Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Jun Chang

Showing results (151-160 of 236) with videos related to

Pageof 24
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 7, 2014
[A new multi-factor risk score system for predicting the outcome after allogenic hematopoietic stem cell transplantation]Jing Liu, Lan-Ping Xu, Dai-Hong Liu, et al.
Haematologica|October 12, 2023
Targeting T<sub>FH</sub> cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an <i>in vitro</i> and <i>in vivo</i> studyNing Ma, Wei-Bing Wu, Xiang-Yu Zhao, et al.
HLA|June 10, 2022
Prevalence and risk factors of antibodies to HLA according to different cut-off values of mean fluorescence intensity in haploidentical allograft candidates: A prospective study of 3805 subjectsNing Ma, Jia-Pei Guo, Xiang-Yu Zhao, et al.
Journal of Hematology & Oncology|February 8, 2017
The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemiaYa-Zhen Qin, Yu Wang, Lan-Ping Xu, et al.
Journal of Hematology & Oncology|July 10, 2015
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation setsYing-Jun Chang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Cellular & Molecular Immunology|January 12, 2022
Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantationXu-Ying Pei, Xue-Fei Liu, Xiang-Yu Zhao, et al.
Blood Science (Baltimore, Md.)|November 24, 2025
Cerebrospinal fluid profile associated with the incidence and outcomes of patients with chronic graft-versus-host disease after haploidentical hematopoietic stem cell transplantationChen Zhao, Hai-Xia Fu, Xiao-Dong Mo, et al.
European Journal of Haematology|January 28, 2017
Viral encephalitis after haplo-identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factorsXiao-Hui Zhang, Jia-Min Zhang, Wei Han, et al.
Clinical and Experimental Medicine|May 13, 2026
Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplantYa Luo, Wen-Min Chen, Xiao-Su Zhao, et al.
Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.
Pageof 24

Showing results (151-160 of 236) with videos related to

Sort By:
Pageof 24
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 7, 2014
[A new multi-factor risk score system for predicting the outcome after allogenic hematopoietic stem cell transplantation]Jing Liu, Lan-Ping Xu, Dai-Hong Liu, et al.
Haematologica|October 12, 2023
Targeting T<sub>FH</sub> cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an <i>in vitro</i> and <i>in vivo</i> studyNing Ma, Wei-Bing Wu, Xiang-Yu Zhao, et al.
HLA|June 10, 2022
Prevalence and risk factors of antibodies to HLA according to different cut-off values of mean fluorescence intensity in haploidentical allograft candidates: A prospective study of 3805 subjectsNing Ma, Jia-Pei Guo, Xiang-Yu Zhao, et al.
Journal of Hematology & Oncology|February 8, 2017
The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemiaYa-Zhen Qin, Yu Wang, Lan-Ping Xu, et al.
Journal of Hematology & Oncology|July 10, 2015
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation setsYing-Jun Chang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Cellular & Molecular Immunology|January 12, 2022
Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantationXu-Ying Pei, Xue-Fei Liu, Xiang-Yu Zhao, et al.
Blood Science (Baltimore, Md.)|November 24, 2025
Cerebrospinal fluid profile associated with the incidence and outcomes of patients with chronic graft-versus-host disease after haploidentical hematopoietic stem cell transplantationChen Zhao, Hai-Xia Fu, Xiao-Dong Mo, et al.
European Journal of Haematology|January 28, 2017
Viral encephalitis after haplo-identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factorsXiao-Hui Zhang, Jia-Min Zhang, Wei Han, et al.
Clinical and Experimental Medicine|May 13, 2026
Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplantYa Luo, Wen-Min Chen, Xiao-Su Zhao, et al.
Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.
Pageof 24